Image (Vonvendi 01)
Not available*
Vonvendi Kit
Product Images NDC 0944-7553
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 38 technical images submitted to the FDA as part of the official labeling for Vonvendi (NDC 0944-7553). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Vonvendi 02)
Figure (Vonvendi 03)
Figure (Vonvendi 04)
Figure (Vonvendi 05)
Figure (Vonvendi 06)
Figure (Vonvendi 07)
Figure (Vonvendi 08)
Figure (Vonvendi 09)
Figure (Vonvendi 10)
Figure (Vonvendi 11)
Figure (Vonvendi 12)
Figure (Vonvendi 13)
Figure (Vonvendi 14)
Figure (Vonvendi 15)
Principal Display Panel (Kit Carton)
Principal Display Panel (650 IU Vial Label)
Principal Display Panel (5 mL Vial Label)
Principal Display Panel (Kit Carton)
Principal Display Panel (1300 IU Vial Label)
Principal Display Panel (10 mL Vial Label)
Vonvendi 22
Vonvendi 23
Vonvendi 24
Vonvendi 25
Vonvendi 26
The text appears to describe a "syringe tip", which is a small, pointed end of a syringe that is used for injecting or dispensing liquids. The copyright symbol suggests that this may be a proprietary term or design belonging to a particular company or manufacturer.*
Vonvendi 27
Vonvendi 28
Vonvendi 29
Vonvendi 30
Vonvendi 31
Vonvendi 32
Vonvendi 33
VONVENDI is a recombinant von Willebrand factor product by BaxaltaUs Inc. The product is non-sterile and non-pyrogenic. The actual potency of the product is not specified in the text. The product is a freeze-dried powder and requires reconstitution before use. The text includes a lot number (G855-65-008-1) and an expiration date.*
Vonvendi 34
VONVENDI is a single-use lyophilized powder of von Willebrand factor (Recombinant) for intravenous administration after reconstitution only. It is manufactured by Baxalta US Inc. and has an NDC code of 0944-7550-01. The label also contains information on lot number and expiration date.*
Vonvendi 35
This is a description of a product that appears to be sterile water for injection. The product code is nbc09s4a-0013-05, and it is intended for use in reconstituting another product. The container is a single-dose and nonpyrogenic, but no antimicrobial agent or other substance appears to have been added to the water. The product should not be used for intravascular injection without the addition of a suitable solute. There is also a lot number and expiration date provided.*
Vonvendi 36
VONVENDI is a recombinant treatment for von Willebrand factor (VWF) deficiency, a bleeding disorder. The product is stored at room temperature and should not be frozen. One package contains 1 g of the medicine, and its components do not contain natural rubber latex. It is not available if further details are missing.*
Vonvendi 37
VONVENDI is a recombinant von Willebrand factor used for intravenous administration after reconstitution. It is sterile, in single-use vials and comes as a lyophilized powder. The lot number is NO COAT °§ H. Its NDC is 0944-7552-01 or 0344755201. VONVENDI is manufactured by Baxalta US Inc. located in Lexington, MA.*
Vonvendi 38
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
